EN
EN
  • ÒµÎñ×Éѯ

    Öйú£º

    Email: marketing@medicilon.com.cn

    ÒµÎñ×ÉѯרÏߣº400-780-8018

    £¨½öÏÞ·þÎñ×Éѯ£¬ÆäËûÊÂÒËÇ벦´ò´¨É³×ܲ¿µç»°£©

    ´¨É³×ܲ¿µç»°: +86 (21) 5859-1500

    º£Í⣺

    +1(781)535-1428(U.S.)

    0044 7790 816 954 (Europe)

    Email:marketing@medicilon.com

ÔÚÏßÁôÑÔ¡Á
µã»÷Çл»

ËÑË÷½á¹û°üº¬ ?500? or §»???/tel: 86(21)5859-1500 µÄÄÚÈÝ

Jul 03,2025
ÌØÒìÐÔRETÒÖÖÆ¼ÁCPT¿É¸ÄÉÆ°¢¶û´Äº£Ä¬²¡£¬±¾Ñо¿ÖÐCPTÓÉÃÀµÏÎ÷»¯Ñ§²¿ÃźϳÉ
The compound was synthesized for Cerepeut Inc. by the Chemistry Branch of Medicilon.
²é¿´¸ü¶à
ÌØÒìÐÔRETÒÖÖÆ¼ÁCPT¿É¸ÄÉÆ°¢¶û´Äº£Ä¬²¡£¬±¾Ñо¿ÖÐCPTÓÉÃÀµÏÎ÷»¯Ñ§²¿ÃźϳÉ
Jul 02,2025
¿Ú·þÓÐЧµÄADAMTS-4/5ÒÖÖÆ¼ÁÒìßÅßáßøõ£°·ÑÜÉúÎ¿ÉÖÎÁƹǹؽÚÑ×£¬±¾Ñо¿Öв¿·Ö»¯ºÏÎïͨ¹ýÃÀµÏÎ÷ºÏ³É
Part of the compound synthesis was performed at Medicilon.
²é¿´¸ü¶à
¿Ú·þÓÐЧµÄADAMTS-4/5ÒÖÖÆ¼ÁÒìßÅßáßøõ£°·ÑÜÉúÎ¿ÉÖÎÁƹǹؽÚÑ×£¬±¾Ñо¿Öв¿·Ö»¯ºÏÎïͨ¹ýÃÀµÏÎ÷ºÏ³É
Jul 02,2025
¿Ú·þIRAK4ÒÖÖÆ¼Á¿ÉÔ¤·À¼±ÐÔºôÎü¾½ÆÈ×ÛºÏÕ÷£¬±¾Ñо¿ÖÐÒÖÖÆ¼Áͨ¹ýÃÀµÏÎ÷ºÏ³É
BAY-1834845 and PF-06650833 are synthesize by Medicilon.
²é¿´¸ü¶à
¿Ú·þIRAK4ÒÖÖÆ¼Á¿ÉÔ¤·À¼±ÐÔºôÎü¾½ÆÈ×ÛºÏÕ÷£¬±¾Ñо¿ÖÐÒÖÖÆ¼Áͨ¹ýÃÀµÏÎ÷ºÏ³É
Jul 02,2025
°ÐÏòHGFµÄÈËÔ´»¯ÖкͿ¹ÌåµÄÁÙ´²Ç°¿ª·¢£¬±¾Ñо¿ÖÐPK/TK¼°ADAͨ¹ýÃÀµÏÎ÷½øÐÐ
Pharmacokinetics, toxicokinetics and anti-drug antibodies of YYB-101 in cynomolgus monkeys were conducted by the Test and Control Article Department of Medicilon Preclinical Research, LLC, in accordance with regulations outlined in the USDA Animal Welfare
²é¿´¸ü¶à
°ÐÏòHGFµÄÈËÔ´»¯ÖкͿ¹ÌåµÄÁÙ´²Ç°¿ª·¢£¬±¾Ñо¿ÖÐPK/TK¼°ADAͨ¹ýÃÀµÏÎ÷½øÐÐ
Jul 02,2025
ASCT1/2ÒÖÖÆ¼Á¿ÉÓÃÓÚÖÎÁƾ«Éñ·ÖÁÑÖ¢ºÍÊÓ¾õÕϰ­£¬±¾Ñо¿ÖÐСÊóPKʵÑéͨ¹ýÃÀµÏÎ÷½øÐÐ
Pharmacokinetic studies in mice for L-4FPG, L-4OHPG, and L-4ClPG were performed by Medicilon.
²é¿´¸ü¶à
ASCT1/2ÒÖÖÆ¼Á¿ÉÓÃÓÚÖÎÁƾ«Éñ·ÖÁÑÖ¢ºÍÊÓ¾õÕϰ­£¬±¾Ñо¿ÖÐСÊóPKʵÑéͨ¹ýÃÀµÏÎ÷½øÐÐ
Jul 02,2025
MCL1ÒÖÖÆ¼ÁÔÚ¶àÖÖʵÌåÁöºÍѪҺÖ×ÁöÄ£ÐÍÖÐÏÔʾ¿¹Ö×ÁöЧ¹û£¬±¾Ñо¿ÖÐҩЧʵÑéͨ¹ýÃÀµÏÎ÷½øÐÐ
CDX studies were performed at Shanghai Medicilon (OS-RC-2). All studies were performed in accordance with animal research guidelines from the Shanghai Medicilon Inc.
²é¿´¸ü¶à
MCL1ÒÖÖÆ¼ÁÔÚ¶àÖÖʵÌåÁöºÍѪҺÖ×ÁöÄ£ÐÍÖÐÏÔʾ¿¹Ö×ÁöЧ¹û£¬±¾Ñо¿ÖÐҩЧʵÑéͨ¹ýÃÀµÏÎ÷½øÐÐ
Jun 12,2025
Ë«°ÐÏòHDACÒÖÖÆ¼ÁºÍATM¼¤»î¼ÁSP-1-303ÒÖÖÆ´Æ¼¤ËØÊÜÌåÑôÐÔÈéÏÙ°©Ï¸°ûÉú³¤£¬±¾Ñо¿ÖÐPKʵÑéͨ¹ýÃÀµÏÎ÷½øÐÐ
Pharmacokinetic studies performed by Medicilon.
²é¿´¸ü¶à
Ë«°ÐÏòHDACÒÖÖÆ¼ÁºÍATM¼¤»î¼ÁSP-1-303ÒÖÖÆ´Æ¼¤ËØÊÜÌåÑôÐÔÈéÏÙ°©Ï¸°ûÉú³¤£¬±¾Ñо¿ÖÐPKʵÑéͨ¹ýÃÀµÏÎ÷½øÐÐ
Jun 12,2025
½âÄÑÌâ | ÀàÆ÷¹Ù¼¼ÊõÈçºÎÖúÁ¦Ö×ÁöÒ©ÀíÑо¿
ÃÀµÏÎ÷ÔÆ½²ÌÃÑûÇëÒ©Àí²¿¸±Ö÷ÈΣ¬AACR Poster AuthorÕÅΡÖÓ²©Ê¿£¬Ëû½«´Ó×ÔÉí·á¸»µÄÑз¢¾­Ñé³ö·¢Îª´ó¼Ò½â´ð¹ØÓÚÀàÆ÷¹Ù¼¼ÊõÔÚÓ¦Óúͷ¢Õ¹ÖеÄÎÊÌâ¡£
²é¿´¸ü¶à
½âÄÑÌâ | ÀàÆ÷¹Ù¼¼ÊõÈçºÎÖúÁ¦Ö×ÁöÒ©ÀíÑо¿
Jun 12,2025
ÐÂÐÍ5-HT3ÊÜÌåÅäÌåÓÐÍûÓÃÓÚÖÎÁÆÉñ¾­¾«Éñ¼²²¡ºÍ賦µÀ¼²²¡£¬±¾Ñо¿ÖÐÒ©ÀíҩЧѧÑо¿Í¨¹ýÃÀµÏÎ÷½øÐÐ
The experiments (Rat colon distension model of IBS-d) were carried out by Medicilon. The protocol complied with and was approved by the Institutional Animal Care and Use Committee and Medicilon is accredited by the NIH Office of laboratory Animal Welfare
²é¿´¸ü¶à
ÐÂÐÍ5-HT3ÊÜÌåÅäÌåÓÐÍûÓÃÓÚÖÎÁÆÉñ¾­¾«Éñ¼²²¡ºÍ賦µÀ¼²²¡£¬±¾Ñо¿ÖÐÒ©ÀíҩЧѧÑо¿Í¨¹ýÃÀµÏÎ÷½øÐÐ
Jun 11,2025
µÚ¶þ´úǰÁÐÏÙËØÊÜÌåÞ׿¹¼Á£¬±¾Ñо¿ÖÐÑÛ²¿PKʵÑéͨ¹ýÃÀµÏÎ÷½øÐÐ
Ocular Pharmacokinetic studies were performed at Medicilon.
²é¿´¸ü¶à
µÚ¶þ´úǰÁÐÏÙËØÊÜÌåÞ׿¹¼Á£¬±¾Ñо¿ÖÐÑÛ²¿PKʵÑéͨ¹ýÃÀµÏÎ÷½øÐÐ
Jun 11,2025
SIRT6±ä¹¹¼¤»î¼ÁÔÚ½áÖ±³¦°©Öз¢»ÓÖÎÁÆ×÷Ó㬱¾Ñо¿ÖÐPKʵÑéͨ¹ýÃÀµÏÎ÷½øÐÐ
Pharmacokinetic studies were performed by Shanghai Medicilon Inc, China, following standard protocols.
²é¿´¸ü¶à
SIRT6±ä¹¹¼¤»î¼ÁÔÚ½áÖ±³¦°©Öз¢»ÓÖÎÁÆ×÷Ó㬱¾Ñо¿ÖÐPKʵÑéͨ¹ýÃÀµÏÎ÷½øÐÐ
Jun 11,2025
ͨ¹ýÁªºÏÖÎÁÆÌá¸ßÃâÒßÁÆ·¨ÁÆÐ§£¬±¾Ñо¿ÖÐÁÙ´²Ç°ÌåÄÚҩЧÑо¿Í¨¹ýÃÀµÏÎ÷½øÐÐ
The flowcytometry (FCM)-based immune profiling panel studies in J558 allograft syngeneic mouse models were performed at Medicilon. In vivo efficacy studies in J558 allograft models in combination with anti-mPD-1, anti-mPD-L1, and anti-mCTLA-4 antibodies w
²é¿´¸ü¶à
ͨ¹ýÁªºÏÖÎÁÆÌá¸ßÃâÒßÁÆ·¨ÁÆÐ§£¬±¾Ñо¿ÖÐÁÙ´²Ç°ÌåÄÚҩЧÑо¿Í¨¹ýÃÀµÏÎ÷½øÐÐ
Apr 29,2025
¡¾Ò»ÆÚÒ»»á¡¿ÎåÔ»áÒéʱ¹âºÏ¼¯£¬May the force be with you
ÎåÔÂÃÀµÏÎ÷½«Ö÷°ì2³¡ÏßÉÏÖ±²¥£¬Í¬Ê±²ÎÓëSwiss Biotech Day 2025¡¢PEGS Boston 2025¡¢APT 2025 3³¡º£Íâ»áÒ飬ÆÚ´ýÓë¸÷λҵÄÚͬÈʽ»Á÷·ÖÏíÒ©ÎïÑз¢ÐÂÇ÷ÊÆ¡£
²é¿´¸ü¶à
¡¾Ò»ÆÚÒ»»á¡¿ÎåÔ»áÒéʱ¹âºÏ¼¯£¬May the force be with you
Apr 10,2025
ÊÀ½çÅÁ½ðÉ­ÈÕ | ¼ÇÒ»¸öÅÁ½ðÉ­²¡»¼ÕߵĿ¹ÅÁ¹ÊÊÂ(ÄÚ¸½·çÏÕ×Ô²âÌâ)
ÃÀµÏÎ÷ÓµÓжàÖÖÏȽøµÄÅÁ½ðÉ­²¡Ä£ÐÍ£¬Èç MPTP ÓÕµ¼µÄÑǼ±ÐÔÄ£ÐÍ¡¢MPTP + ±û»ÇÊæÓÕµ¼µÄÂýÐÔÄ£ÐÍ¡¢Oxotremorine ÓÕµ¼µÄÕð²ü / Á÷ÏÑÄ£Ð͵ȡ£
²é¿´¸ü¶à
ÊÀ½çÅÁ½ðÉ­ÈÕ | ¼ÇÒ»¸öÅÁ½ðÉ­²¡»¼ÕߵĿ¹ÅÁ¹ÊÊÂ(ÄÚ¸½·çÏÕ×Ô²âÌâ)
Mar 27,2025
ÃÀµÏÎ÷SPR·Ö×Ó»¥×÷·þÎñ
ÃÀµÏÎ÷µÄSPRÆÀ¼Ûƽ̨Å䱸¸ßÁéÃô¶ÈµÄBiacore 8KÉ豸£¬¸²¸Ç´Ó·Ö×ÓÉè¼Æµ½»úÖÆÑо¿µÄ¶à¸ö½×¶Î£¬ÖúÁ¦¿Í»§ÉîÈëÁ˽âÒ©ÎïÓë°ÐµãµÄÏ໥×÷Óá£
²é¿´¸ü¶à
ÃÀµÏÎ÷SPR·Ö×Ó»¥×÷·þÎñ
Mar 26,2025
¡¾Ò»ÆÚÒ»»á¡¿4ÔÂÖ±²¥ÉÏÏߣ¡ÃÀµÏÎ÷ÒýÁìÌ½ÃØÈ«ÇòÐÐÒµ´ó»á£¬¹²¸°Ç°ÑØÖªÊ¶Ê¢Ñç
ËÄÔÂÃÀµÏÎ÷½«Ö÷°ì3³¡ÏßÉÏÖ±²¥£¬Í¬Ê±²ÎÓëµÚ6½ìBIONNOVAÉúÎïÒ½Ò©´´ÐÂÕßÂÛ̳ôßÕ¹ÀÀ»á¡¢AACR 2025¡¢Nordic Precision Medicine Forum 2025µÈ5³¡ÐÐÒµ»áÒ飬ÆÚ´ýÓë¸÷λҵÄÚͬÈʽ»Á÷·ÖÏíÒ©ÎïÑз¢ÐÂÇ÷ÊÆ¡£
²é¿´¸ü¶à
¡¾Ò»ÆÚÒ»»á¡¿4ÔÂÖ±²¥ÉÏÏߣ¡ÃÀµÏÎ÷ÒýÁìÌ½ÃØÈ«ÇòÐÐÒµ´ó»á£¬¹²¸°Ç°ÑØÖªÊ¶Ê¢Ñç
Nov 01,2024
¡¾Ò»ÆÚÒ»»á¡¿ÃÀµÏÎ÷11ÔÂÖ±²¥£¬É³Áú£¬ÐÐÒµÕ¹»á´ó·ÅËÍ£¬ÆÚ´ýÓëÄãÈ«ÇòÏà»á
ÃÀµÏÎ÷½«ÓÚ2024Äê11ÔÂÖ÷°ì2³¡ÏßÉÏÖ±²¥£¬Í¬Ê±²ÎÓë15th World ADC San Diego 2024¡¢SITC 2024ºÍµÚÊ®Æß½ì°ÙÊÀ»¯Ñ§ÖÆÒ©¹ú¼Ê´ó»áôßÕ¹ÀÀ»áµÈ5³¡º£ÄÚÍâÉúÎïÒ½Ò©ÐÐÒµ»áÒé¡£
²é¿´¸ü¶à
¡¾Ò»ÆÚÒ»»á¡¿ÃÀµÏÎ÷11ÔÂÖ±²¥£¬É³Áú£¬ÐÐÒµÕ¹»á´ó·ÅËÍ£¬ÆÚ´ýÓëÄãÈ«ÇòÏà»á
Oct 25,2024
World ADC | ÃÀµÏÎ÷ÑûÄú¹²¸°µÚ15½ìÊÀ½ç¿¹ÌåÒ©ÎïżÁª´ó»á
ÃÀµÏÎ÷ÃÀ¹úÍŶӽ«ÁÁÏà2024Äê11ÔÂ4ÈÕ-7ÈÕ¾Ù°ìµÄÊÀ½ç¿¹ÌåÒ©ÎïżÁª´ó»á£¨World ADC San Diego£©£¬Õ¹Ê¾ÃÀµÏÎ÷ADCһվʽÑз¢·þÎñÄÜÁ¦£¬Õ¹Î»ºÅÊÇ#512¡£
²é¿´¸ü¶à
World ADC | ÃÀµÏÎ÷ÑûÄú¹²¸°µÚ15½ìÊÀ½ç¿¹ÌåÒ©ÎïżÁª´ó»á
Oct 18,2024
¡¾°¢¶û´Äº£Ä¬²¡¡¿Êý¹ÜÆëÏ£¡AD¶à°ÐµãÖÎÁÆÒ©ÎïµÄÉè¼ÆÓ뿪·¢
°¢¶û´Äº£Ä¬²¡ÊÇÒ»ÖÖÑÏÖØµÄ½øÐÐÐÔÉñ¾­ÍËÐÐÐÔ¼²²¡£¬ÃÀµÏÎ÷Ϊ°¢¶û´Äº£Ä¬²¡ÖÎÁÆÒ©ÎïµÄ¿ª·¢Ìṩ¶àÖÖÌåÄÚÍâ»îÐÔÑо¿·þÎñ£¬Òѽ¨Á¢¶àÖְеãÌåÍâÉú»¯»îÐÔ¼ì²â¡¢Ï¸°ûˮƽ»îÐÔ¼ì²â¡¢ÒÔ¼°¶¯ÎïÌåÄÚҩЧģÐ͵ȷþÎñ¡£
²é¿´¸ü¶à
¡¾°¢¶û´Äº£Ä¬²¡¡¿Êý¹ÜÆëÏ£¡AD¶à°ÐµãÖÎÁÆÒ©ÎïµÄÉè¼ÆÓ뿪·¢
Sep 27,2024
ÃÀµÏÎ÷°¢¶û×Ⱥ£Ä¬²¡ÁÙ´²Ç°Ñо¿Ä£Ðͼ°Ò©Ð§Ñо¿°¸Àý
ÃÀµÏÎ÷ҩЧƽ̨ӵÓзḻµÄADÏîÄ¿¾­Ñé¡£ÎÒÃǸù¾Ý¹©ÊÔÆ·×÷ÓûúÖÆÑ¡ÔñºÏÊʵ͝ÎïÄ£ÐÍ£»ÔËÓþ­µäµÄMorrisË®ÃÔ¹¬²âÊÔ£¬²¢½áºÏÏȽøµÄCognitionWall²âÊÔ£¬½ø¶ø¸üÏêϸµØ·ÖÎöÓëÈÏÖªºÍ¼ÇÒäÏà¹ØµÄÐÐΪ±ä»¯£»´ËÍ⣬ͨ¹ý²¡ÀíºÍ·Ö×Óϸ°ûѧ²âÊÔ½á¹ûµÄ×ÛºÏÆÀ¹À£¬È«ÃæÆÀ¼Û¿¹ADÒ©ÎïµÄÁÙ´²Ç°ÁÆÐ§¡£
²é¿´¸ü¶à
ÃÀµÏÎ÷°¢¶û×Ⱥ£Ä¬²¡ÁÙ´²Ç°Ñо¿Ä£Ðͼ°Ò©Ð§Ñо¿°¸Àý
¡Á
ËÑË÷ÑéÖ¤
µã»÷Çл»